[17]唐江华,周维.CXCL9和碳酸酐酶Ⅸ在鼻咽癌患者血清中的表达及其临床意义[J].实用癌症杂志,2016,31(11):1795-1798.[18]AMARAS,CHAARI,KHIARIM,etal.Stromalcellderivedfactor-1andCXCR4expressionincolorectalcancerpromotelivermetastasis[J].CancerBiomark,2015,15(6):869-879.[19]程波,覃纲.基质细胞衍生因子1及其受体趋化因子受体4生物学轴与头颈肿瘤[J].医学综述,2016,22(24):4828-4831.[20]QIAON,WANGL,WANGT,etal.InflammatoryCXCL12-CXCR4/CXCR7axismediatesG-proteinsignalingpathwaytoinfluencetheinvasionandmigrationofnasopharyngealcarcino-macells[J].TumourBiol,2016,37(6):8169-8179.[21]HUB,FANH,LVX,etal.PrognosticsignificanceofCXCL5expressionincancerpatients:ameta-analysis[J].CancerCellInt,2018,18:68.[22]QIUWZ,ZHANGHB,XIAWX,etal.TheCXCL5/CXCR2axiscontributestotheepithelial-mesenchymaltransitionofnasopharyngealcarcinomacellsbyactivatingERK/GSK-3beta/snailsignalling[J].JExpClinCancerRes,2018,37(1):85.[23]LIH,CHENX,ZENGW,etal.Radiation-EnhancedEx-pressionofCCL22inNasopharyngealCarcinomaisAsso-ciatedWithCCR4(+)CD8TCellRecruitment[J].IntJRadiatOncolBiolPhys,2020,108(1):126-139.[24]YANGJ,LVX,CHENJ,etal.CCL2-CCR2axispro-motesmetastasisofnasopharyngealcarcinomabyactiva-tingERK1/2-MMP2/9pathway[J].Oncotarget,2016,7(13):15632-15647.[25]孙国义,吴宝俊,詹红星.趋化因子受体7与血管内皮生长因子-C异常高表达与鼻咽癌患者淋巴结转移及预后的关系[J].中国肿瘤临床与康复,2019,26(3):272-275.[26]WHYTECE,OSMANM,KARAEE,etal.ACKR4re-strainsantitumorimmunitybyregulatingCCL21[J].JExpMed,2020,217(6):e20190634.(收稿日期:2022-03-14修回日期:2022-09-08)△通信作者,E-mail:306933581@qq.com。·综述·DOI:10.3969/j.issn.1672-9455.2023.04.032截肢患者创伤后成长的研究进展袁颖1综述,张小梅2,刘灵巧3,杨娇3,胡莹4,张春丽5△审校1.华中科技大学同济医学院附属协和医院手外科,湖北武汉430022;2.武汉市精神卫生中心,湖北武汉430012;3.宜昌市中心医院呼吸内科,湖北宜昌443003;4湖北职业技术学院,湖北孝感432000;5.黄冈市中心医院护理部,湖北黄冈438800关键词:创伤后成长;截肢;心理疗法中图法分类号:R658.3文献标志码:A文章编号:1672-9455(2023)04-0563-05因疾病或伤口复杂感染等...
